Also called: SMA
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is a group of genetic diseases that damages and kills motor neurons. Motor neurons are a type of nerve cell in the spinal cord and lower part of the brain. They control movement in your arms, legs, face, chest, throat, and tongue.
As the motor neurons die off, your muscles start to weaken and atrophy (waste away). The muscle damage gets worse over time and can affect speaking, walking, swallowing, and breathing.
There are different types of SMA. They are based on how serious the disease is and when the symptoms start:
- Type l is also called Werdnig-Hoffman disease or infantile-onset SMA. It is the most severe type. It is also the most common. Babies with this type usually show signs of the disease before 6 months of age. In more severe cases, the signs show up even before or just after birth (Types 0 or 1A). The babies may have trouble swallowing and breathing and may not move around a lot. They have chronic shortening of muscles or tendons (called contractures). They usually cannot sit up without help. Without treatment, many children with this type will die before 2 years of age.
- Type ll is a moderate to severe type of SMA. It usually first noticed between 6 and 18 months of age. Most children with this type can sit without support but cannot stand or walk without help. They may also have trouble breathing. They can usually live into adolescence or young adulthood.
- Type lll is also called Kugelberg-Welander disease. It is the mildest type that affects children. The signs of the disease usually show up after age 18 months. Children with this type can walk by themselves but may have trouble running, getting up from a chair, or climbing stairs. They may also have scoliosis (curvature of the spine), contractures, and respiratory infections. With treatment, most children with this type will have a normal lifespan.
- Type IV is rare and often mild. It usually causes symptoms after 21 years of age. The symptoms include mild to moderate leg muscle weakness, tremors, and mild breathing problems. The symptoms slowly get worse over time. People with this type of SMA have a normal lifespan.
Most types of SMA are caused by a change in the SMN1 gene. This gene is responsible for making a protein that the motor neurons need to be healthy and to function. But when part of the SMN1 gene is missing or abnormal, there isn't enough protein for the motor neurons. This causes the motor neurons to die off.
Most people have two copies of the SM1 gene - one from each parent. SMA normally only happens when both copies have the gene change. If only one copy has the change, there usually aren't any symptoms. But that gene could be passed down from parent to child.
Some of the less common types of SMA may be caused by changes in other genes.
Your health care provider may use many tools to diagnose SMA:
- A physical exam
- A medical history, including asking about family history
- Genetic testing to check for the gene changes that cause SMA
- Electromyography and nerve conduction studies and a muscle biopsy may be done, especially if no gene changes were found
Parents who have a family history of SMA may want to do a prenatal test to check to see whether their baby has an SMN1 gene change. An amniocentesis or in some cases a chorionic villi sampling (CVS) is used to get the sample for testing.
In some states, genetic testing for SMA is part of newborn screening tests.
There is no cure for SMA. Treatments can help manage symptoms and prevent complications. They may include:
- Medicines to help the body make more of the proteins that the motor neurons need
- Gene therapy for children under 2 years of age
- Physical, occupational, and rehabilitation therapy to help to improve posture and the mobility of the joints. These therapies may also improve blood flow and slow muscle weakness and atrophy. Some people may also need therapy for trouble speaking, chewing, and swallowing.
- Assistive devices such as supports or braces, orthotics, speech synthesizers, and wheelchairs to help people stay more independent
- Good nutrition and a balanced diet to help maintain weight and strength. Some people might need a feeding tube in order to get the nutrition they need.
- Breathing support for people who have muscle weakness in the neck, throat, and chest. The support may include devices to help with breathing during the day and to prevent sleep apnea at night. Some people might need to be on a ventilator.
It sits within Brain and Nerves and Genetics/Birth Defects.
The lead U.S. institute for this subject is the National Institute of Neurological Disorders and Stroke.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Spinal Muscular Atrophy
457 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- A Real-World Medical Chart Review of Spinal Muscular Atrophy Patients Treated With Onasemnogene Abeparvovec in Saudi ArabiaNovartis Pharmaceuticals
- Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen InsensitivityEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- iBCI Optimization for Veterans With ParalysisVA Office of Research and Development
- Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium)Biogen
- A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)ORIC Pharmaceuticals
- Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young AdultsNational Institutes of Health Clinical Center (CC)
Research already completed
- Equine-Assisted Physiotherapy for Spinal Muscular AtrophyCharles University, Czech Republic
- Effects of Developmental Support for Mothers of Infants With Spinal Muscular AtrophyMedipol University
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- About Spinal Muscular Atrophy (SMA): Frequently Asked QuestionsSpinal Muscular Atrophy Foundation
- Describing SMACure SMA
- Spinal Muscular AtrophyNational Institute of Neurological Disorders and Stroke
- Spinal Muscular Atrophy (SMA)Muscular Dystrophy Association
Symptoms
- Kennedy's Disease SymptomsKennedy's Disease Association
- SMArt Moves: Early ActionCure SMA
Diagnosis and Tests
- Electromyography (EMG) and Nerve Conduction StudiesNational Library of Medicine
- Newborn Screening for SMACure SMA
- SMA: Testing & DiagnosisCure SMA
Treatments and Therapies
- SMArt Moves: Early TreatmentCure SMA
Prevention and Risk Factors
- GeneticsCure SMA
Living With
- Medical Issues: Breathing Risks and CareCure SMA
- Medical Issues: MusculoskeletalCure SMA
- Medical Issues: NutritionCure SMA
Genetics
- Learning about Spinal Muscular AtrophyNational Human Genome Research Institute
- Spinal and bulbar muscular atrophy: MedlinePlus GeneticsNational Library of Medicine
- Spinal muscular atrophy with lower extremity predominance: MedlinePlus GeneticsNational Library of Medicine
- Spinal muscular atrophy with progressive myoclonic epilepsy: MedlinePlus GeneticsNational Library of Medicine
- Spinal muscular atrophy: MedlinePlus GeneticsNational Library of Medicine
- X-linked infantile spinal muscular atrophy: MedlinePlus GeneticsNational Library of Medicine
Clinical Trials
- ClinicalTrials.gov: Muscular Atrophy, SpinalNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Muscular Atrophy, Spinal. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Spinal Muscular Atrophy, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.